Sadhana Jackson

MD

Bethesda, MD USA

sadhana_jackson_-_2020.jpg

About

Adjunct Investigator

National Cancer Institute

Dr. Jackson’s research interests center on evaluating the blood-brain barrier (BBB) of malignant gliomas.  Her clinical and translational research focuses on transiently disrupting the BBB by pharmacologic means, in an effort to improve cytotoxic therapy to the central nervous system.  She uses brain microdialysis, pharmacokinetic analysis, and preclinical models to study central nervous system (CNS) pharmacology. Dr. Jackson also leads collaborative preclinical and clinical studies focused on understanding BBB integrity in normal brain and malignant gliomas with the goal of developing novel treatment strategies for brain tumor patients.